Skip to content

Cvs Health

NYSE: CVS · USD

Cvs Health financials

6 charts

Revenue

USD millions

$106,096M
Cvs Health Revenue. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodRevenue
FY 2009 Q2$24,871.1M; Change unavailable vs FY 2009 Q1
FY 2009 Q3$24,641.9M; −0.9% vs FY 2009 Q2
FY 2009 Q4$25,822M; +4.8% vs FY 2009 Q3
FY 2010 Q1$23,760M; −8.0% vs FY 2009 Q4
FY 2010 Q2$24,007M; +1.0% vs FY 2010 Q1
FY 2010 Q3$23,875M; −0.5% vs FY 2010 Q2
FY 2010 Q4$24,771M; +3.8% vs FY 2010 Q3
FY 2011 Q1$25,880M; +4.5% vs FY 2010 Q4
FY 2011 Q2$26,629M; +2.9% vs FY 2011 Q1
FY 2011 Q3$26,674M; +0.2% vs FY 2011 Q2
FY 2011 Q4$28,317M; +6.2% vs FY 2011 Q3
FY 2012 Q1$30,798M; +8.8% vs FY 2011 Q4
FY 2012 Q2$30,714M; −0.3% vs FY 2012 Q1
FY 2012 Q3$30,227M; −1.6% vs FY 2012 Q2
FY 2012 Q4$31,394M; +3.9% vs FY 2012 Q3
FY 2013 Q1$30,763M; −2.0% vs FY 2012 Q4
FY 2013 Q2$31,248M; +1.6% vs FY 2013 Q1
FY 2013 Q3$31,968M; +2.3% vs FY 2013 Q2
FY 2013 Q4$32,830M; +2.7% vs FY 2013 Q3
FY 2014 Q1$32,689M; −0.4% vs FY 2013 Q4
FY 2014 Q2$34,602M; +5.9% vs FY 2014 Q1
FY 2014 Q3$35,021M; +1.2% vs FY 2014 Q2
FY 2014 Q4$37,055M; +5.8% vs FY 2014 Q3
FY 2015 Q1$36,332M; −2.0% vs FY 2014 Q4
FY 2015 Q2$37,169M; +2.3% vs FY 2015 Q1
FY 2015 Q3$38,644M; +4.0% vs FY 2015 Q2
FY 2015 Q4$41,145M; +6.5% vs FY 2015 Q3
FY 2016 Q1$43,215M; +5.0% vs FY 2015 Q4
FY 2016 Q2$43,725M; +1.2% vs FY 2016 Q1
FY 2016 Q3$44,615M; +2.0% vs FY 2016 Q2
FY 2016 Q4$45,971M; +3.0% vs FY 2016 Q3
FY 2017 Q1$44,514M; −3.2% vs FY 2016 Q4
FY 2017 Q2$45,685M; +2.6% vs FY 2017 Q1
FY 2017 Q3$46,181M; +1.1% vs FY 2017 Q2
FY 2017 Q4$48,385M; +4.8% vs FY 2017 Q3
FY 2018 Q1$45,693M; −5.6% vs FY 2017 Q4
FY 2018 Q2$46,708M; +2.2% vs FY 2018 Q1
FY 2018 Q3$47,269M; +1.2% vs FY 2018 Q2
FY 2018 Q4$54,424M; +15.1% vs FY 2018 Q3
FY 2019 Q1$61,397M; +12.8% vs FY 2018 Q4
FY 2019 Q2$63,138M; +2.8% vs FY 2019 Q1
FY 2019 Q3$64,547M; +2.2% vs FY 2019 Q2
FY 2019 Q4$66,889M; +3.6% vs FY 2019 Q3
FY 2020 Q1$66,755M; −0.2% vs FY 2019 Q4
FY 2020 Q2$65,341M; −2.1% vs FY 2020 Q1
FY 2020 Q3$67,056M; +2.6% vs FY 2020 Q2
FY 2020 Q4$69,554M; +3.7% vs FY 2020 Q3
FY 2021 Q1$69,097M; −0.7% vs FY 2020 Q4
FY 2021 Q2$72,616M; +5.1% vs FY 2021 Q1
FY 2021 Q3$73,794M; +1.6% vs FY 2021 Q2
FY 2021 Q4$76,604M; +3.8% vs FY 2021 Q3
FY 2022 Q1$76,826M; +0.3% vs FY 2021 Q4
FY 2022 Q2$80,636M; +5.0% vs FY 2022 Q1
FY 2022 Q3$81,159M; +0.6% vs FY 2022 Q2
FY 2022 Q4$83,846M; +3.3% vs FY 2022 Q3
FY 2023 Q1$85,278M; +1.7% vs FY 2022 Q4
FY 2023 Q2$88,921M; +4.3% vs FY 2023 Q1
FY 2023 Q3$89,764M; +0.9% vs FY 2023 Q2
FY 2023 Q4$93,813M; +4.5% vs FY 2023 Q3
FY 2024 Q1$88,437M; −5.7% vs FY 2023 Q4
FY 2024 Q2$91,234M; +3.2% vs FY 2024 Q1
FY 2024 Q3$95,428M; +4.6% vs FY 2024 Q2
FY 2024 Q4$97,710M; +2.4% vs FY 2024 Q3
FY 2025 Q1$94,588M; −3.2% vs FY 2024 Q4
FY 2025 Q2$98,915M; +4.6% vs FY 2025 Q1
FY 2025 Q3$102,871M; +4.0% vs FY 2025 Q2
FY 2025 Q4$105,693M; +2.7% vs FY 2025 Q3
FY 2026 Q1$100,426M; −5.0% vs FY 2025 Q4
FY 2026 Q2$106,096M; +5.6% vs FY 2026 Q1
Jun 30, 2009 through Sep 25, 2026

Free cash flow

USD millions

$5,654M
Cvs Health Free cash flow. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodFree cash flow
FY 2009 Q2$-73.1M; Change unavailable vs FY 2009 Q1
FY 2009 Q3$246.2M; +436.8% vs FY 2009 Q2
FY 2009 Q4$1,008.9M; +309.8% vs FY 2009 Q3
FY 2010 Q1$659M; −34.7% vs FY 2009 Q4
FY 2010 Q2$187M; −71.6% vs FY 2010 Q1
FY 2010 Q3$779M; +316.6% vs FY 2010 Q2
FY 2010 Q4$1,149M; +47.5% vs FY 2010 Q3
FY 2011 Q1$1,557M; +35.5% vs FY 2010 Q4
FY 2011 Q2$806M; −48.2% vs FY 2011 Q1
FY 2011 Q3$1,504M; +86.6% vs FY 2011 Q2
FY 2011 Q4$117M; −92.2% vs FY 2011 Q3
FY 2012 Q1$2,410M; +1959.8% vs FY 2011 Q4
FY 2012 Q2$789M; −67.3% vs FY 2012 Q1
FY 2012 Q3$427M; −45.9% vs FY 2012 Q2
FY 2012 Q4$1,015M; +137.7% vs FY 2012 Q3
FY 2013 Q1$1,322M; +30.2% vs FY 2012 Q4
FY 2013 Q2$416M; −68.5% vs FY 2013 Q1
FY 2013 Q3$1,177M; +182.9% vs FY 2013 Q2
FY 2013 Q4$884M; −24.9% vs FY 2013 Q3
FY 2014 Q1$1,784M; +101.8% vs FY 2013 Q4
FY 2014 Q2$394M; −77.9% vs FY 2014 Q1
FY 2014 Q3$1,100M; +179.2% vs FY 2014 Q2
FY 2014 Q4$2,723M; +147.5% vs FY 2014 Q3
FY 2015 Q1$1,565M; −42.5% vs FY 2014 Q4
FY 2015 Q2$514M; −67.2% vs FY 2015 Q1
FY 2015 Q3$1,272M; +147.5% vs FY 2015 Q2
FY 2015 Q4$2,694M; +111.8% vs FY 2015 Q3
FY 2016 Q1$1,814M; −32.7% vs FY 2015 Q4
FY 2016 Q2$1,107M; −39.0% vs FY 2016 Q1
FY 2016 Q3$3,420M; +208.9% vs FY 2016 Q2
FY 2016 Q4$1,504M; −56.0% vs FY 2016 Q3
FY 2017 Q1$3,076M; +104.5% vs FY 2016 Q4
FY 2017 Q2$1,568M; −49.0% vs FY 2017 Q1
FY 2017 Q3$2,087M; +33.1% vs FY 2017 Q2
FY 2017 Q4$-642M; −130.8% vs FY 2017 Q3
FY 2018 Q1$1,873M; +391.7% vs FY 2017 Q4
FY 2018 Q2$2,504M; +33.7% vs FY 2018 Q1
FY 2018 Q3$557M; −77.8% vs FY 2018 Q2
FY 2018 Q4$1,894M; +240.0% vs FY 2018 Q3
FY 2019 Q1$1,232M; −35.0% vs FY 2018 Q4
FY 2019 Q2$4,765M; +286.8% vs FY 2019 Q1
FY 2019 Q3$2,327M; −51.2% vs FY 2019 Q2
FY 2019 Q4$2,067M; −11.2% vs FY 2019 Q3
FY 2020 Q1$2,563M; +24.0% vs FY 2019 Q4
FY 2020 Q2$6,671M; +160.3% vs FY 2020 Q1
FY 2020 Q3$1,340M; −79.9% vs FY 2020 Q2
FY 2020 Q4$2,854M; +113.0% vs FY 2020 Q3
FY 2021 Q1$2,063M; −27.7% vs FY 2020 Q4
FY 2021 Q2$5,361M; +159.9% vs FY 2021 Q1
FY 2021 Q3$4,913M; −8.4% vs FY 2021 Q2
FY 2021 Q4$3,408M; −30.6% vs FY 2021 Q3
FY 2022 Q1$2,512M; −26.3% vs FY 2021 Q4
FY 2022 Q2$5,035M; +100.4% vs FY 2022 Q1
FY 2022 Q3$8,543M; +69.7% vs FY 2022 Q2
FY 2022 Q4$-2,640M; −130.9% vs FY 2022 Q3
FY 2023 Q1$6,454M; +344.5% vs FY 2022 Q4
FY 2023 Q2$5,317M; −17.6% vs FY 2023 Q1
FY 2023 Q3$2,171M; −59.2% vs FY 2023 Q2
FY 2023 Q4$-3,547M; −263.4% vs FY 2023 Q3
FY 2024 Q1$4,198M; +218.4% vs FY 2023 Q4
FY 2024 Q2$2,451M; −41.6% vs FY 2024 Q1
FY 2024 Q3$-1,415M; −157.7% vs FY 2024 Q2
FY 2024 Q4$1,092M; +177.2% vs FY 2024 Q3
FY 2025 Q1$3,813M; +249.2% vs FY 2024 Q4
FY 2025 Q2$1,290M; −66.2% vs FY 2025 Q1
FY 2025 Q3$98M; −92.4% vs FY 2025 Q2
FY 2025 Q4$2,606M; +2559.2% vs FY 2025 Q3
FY 2026 Q1$3,400M; +30.5% vs FY 2025 Q4
FY 2026 Q2$5,654M; +66.3% vs FY 2026 Q1

Net margin

%

2.81%
Cvs Health Net margin. Reported fiscal history.
Fiscal period%
FY 2009 Q23.56%
FY 2009 Q34.14%
FY 2009 Q44.06%
FY 2010 Q13.24%
FY 2010 Q23.42%
FY 2010 Q33.39%
FY 2010 Q44.14%
FY 2011 Q12.76%
FY 2011 Q23.06%
FY 2011 Q33.25%
FY 2011 Q43.75%
FY 2012 Q12.52%
FY 2012 Q23.14%
FY 2012 Q33.33%
FY 2012 Q43.6%
FY 2013 Q13.11%
FY 2013 Q23.59%
FY 2013 Q33.92%
FY 2013 Q43.85%
FY 2014 Q13.45%
FY 2014 Q23.6%
FY 2014 Q32.71%
FY 2014 Q43.56%
FY 2015 Q13.36%
FY 2015 Q23.42%
FY 2015 Q33.23%
FY 2015 Q43.64%
FY 2016 Q12.65%
FY 2016 Q22.11%
FY 2016 Q33.45%
FY 2016 Q43.71%
FY 2017 Q12.14%
FY 2017 Q22.4%
FY 2017 Q32.78%
FY 2017 Q46.79%
FY 2018 Q12.18%
FY 2018 Q2-5.49%
FY 2018 Q32.94%
FY 2018 Q4-0.77%
FY 2019 Q12.32%
FY 2019 Q23.07%
FY 2019 Q32.37%
FY 2019 Q42.61%
FY 2020 Q13.01%
FY 2020 Q24.55%
FY 2020 Q31.83%
FY 2020 Q41.4%
FY 2021 Q13.22%
FY 2021 Q23.83%
FY 2021 Q32.17%
FY 2021 Q41.7%
FY 2022 Q13.01%
FY 2022 Q23.66%
FY 2022 Q3-4.21%
FY 2022 Q42.75%
FY 2023 Q12.5%
FY 2023 Q22.14%
FY 2023 Q32.52%
FY 2023 Q42.18%
FY 2024 Q11.26%
FY 2024 Q21.94%
FY 2024 Q30.09%
FY 2024 Q41.68%
FY 2025 Q11.88%
FY 2025 Q21.03%
FY 2025 Q3-3.86%
FY 2025 Q42.78%
FY 2026 Q12.93%
FY 2026 Q22.81%

P/E

× · TTM · Daily

23.46×
Cvs Health P/E. Monthly closing observations; inspect daily values with the chart arrow keys.
Close date× · TTM · DailyFinancials through
2011-02-2813.11×2010-09-30
2011-03-3113.61×2010-09-30
2011-04-2914.36×2010-09-30
2011-05-3115.34×2010-09-30
2011-06-3014.9×2010-09-30
2011-07-2914.41×2010-09-30
2011-08-3114.24×2010-09-30
2011-09-3013.32×2010-09-30
2011-10-3114.41×2010-09-30
2011-11-3015.4×2010-09-30
2011-12-3016.17×2010-09-30
2012-01-3116.55×2010-09-30
2012-02-2917.88×2010-09-30
2012-03-3017.76×2010-09-30
2012-04-3017.69×2010-09-30
2012-05-3117.82×2010-09-30
2012-06-2918.53×2010-09-30
2012-07-3117.94×2010-09-30
2012-08-3118.06×2010-09-30
2012-09-2819.2×2010-09-30
2012-10-3118.4×2010-09-30
2012-11-3018.44×2010-09-30
2012-12-3119.17×2010-09-30
2013-01-3120.3×2010-09-30
2013-02-2820.01×2011-09-30
2013-03-2821.53×2011-09-30
2013-04-3022.78×2011-09-30
2013-05-3122.54×2011-09-30
2013-06-2822.38×2011-09-30
2013-07-3124.07×2011-09-30
2013-08-3022.72×2011-09-30
2013-09-3022.22×2011-09-30
2013-10-3124.37×2011-09-30
2013-11-2926.21×2011-09-30
2013-12-3128.02×2011-09-30
2014-01-3126.51×2011-09-30
2014-02-2824.44×2012-09-30
2014-03-3125.02×2012-09-30
2014-04-3024.3×2012-09-30
2014-05-3019.54×2014-03-31
2014-06-3018.81×2014-03-31
2014-07-3119.05×2014-03-31
2014-08-2919.83×2014-03-31
2014-09-3019.86×2014-03-31
2014-10-3121.41×2014-03-31
2014-11-2822.8×2014-03-31
2014-12-3124.03×2014-03-31
2015-01-3024.49×2014-03-31
2015-02-2725.92×2014-03-31
2015-03-3125.75×2014-03-31
2015-04-3024.78×2014-03-31
2015-05-2925.55×2014-03-31
2015-06-3026.17×2014-03-31
2015-07-3128.06×2014-03-31
2015-08-3125.55×2014-03-31
2015-09-3024.07×2014-03-31
2015-10-3024.65×2014-03-31
2015-11-3023.48×2014-03-31
2015-12-3124.4×2014-03-31
2016-01-2924.1×2014-03-31
2016-02-2924.65×2014-09-30
2016-03-3126.32×2014-09-30
2016-04-2925.5×2014-09-30
2016-05-3124.47×2014-09-30
2016-06-3024.29×2014-09-30
2016-07-2923.52×2014-09-30
2016-08-3123.7×2014-09-30
2016-09-3022.58×2014-09-30
2016-10-3121.34×2014-09-30
2016-11-3019.51×2014-09-30
2016-12-3020.02×2014-09-30
2017-01-3119.99×2014-09-30
2017-02-2817.85×2015-09-30
2017-03-3117.39×2015-09-30
2017-04-2818.26×2015-09-30
2017-05-3117.02×2015-09-30
2017-06-3017.83×2015-09-30
2017-07-3117.71×2015-09-30
2017-08-3117.13×2015-09-30
2017-09-2918.02×2015-09-30
2017-10-3115.18×2015-09-30
2017-11-3016.97×2015-09-30
2017-12-2916.06×2015-09-30
2018-01-3117.43×2015-09-30
2018-02-2810.41×2017-12-31
2018-03-299.56×2017-12-31
2018-04-3010.74×2017-12-31
2018-05-319.75×2017-12-31
2018-06-299.89×2017-12-31
2018-07-319.97×2017-12-31
2018-08-3111.57×2017-12-31
2018-09-2812.1×2017-12-31
2018-10-3111.13×2017-12-31
2018-11-3012.33×2017-12-31
2018-12-3110.07×2017-12-31
2019-01-3110.08×2017-12-31
2019-02-288.89×2017-12-31
2019-03-29—2018-12-31
2019-04-30—2018-12-31
2019-05-31—2018-12-31
2019-06-28—2018-12-31
2019-07-31—2018-12-31
2019-08-30—2018-12-31
2019-09-30—2018-12-31
2019-10-31—2018-12-31
2019-11-29—2018-12-31
2019-12-31—2018-12-31
2020-01-31—2018-12-31
2020-02-28—2018-12-31
2020-03-31—2018-12-31
2020-04-30—2018-12-31
2020-05-2911.92×2020-03-31
2020-06-3011.81×2020-03-31
2020-07-3111.44×2020-03-31
2020-08-319.88×2020-06-30
2020-09-309.29×2020-06-30
2020-10-308.92×2020-06-30
2020-11-3011.21×2020-09-30
2020-12-3111.29×2020-09-30
2021-01-2911.85×2020-09-30
2021-02-2611.27×2020-09-30
2021-03-3112.44×2020-09-30
2021-04-3012.63×2020-09-30
2021-05-2815.45×2021-03-31
2021-06-3014.92×2021-03-31
2021-07-3014.72×2021-03-31
2021-08-3115.92×2021-06-30
2021-09-3015.63×2021-06-30
2021-10-2916.45×2021-06-30
2021-11-3015.62×2021-09-30
2021-12-3118.09×2021-09-30
2022-01-3118.68×2021-09-30
2022-02-2817.53×2021-12-31
2022-03-3117.12×2021-12-31
2022-04-2916.26×2021-12-31
2022-05-3116.36×2021-12-31
2022-06-3015.67×2021-12-31
2022-07-2916.18×2021-12-31
2022-08-3116.6×2021-12-31
2022-09-3016.13×2021-12-31
2022-10-3116.02×2021-12-31
2022-11-3017.23×2021-12-31
2022-12-3015.76×2021-12-31
2023-01-3114.92×2021-12-31
2023-02-2814.13×2021-12-31
2023-03-3112.57×2021-12-31
2023-04-2812.4×2021-12-31
2023-05-3111.51×2021-12-31
2023-06-3011.69×2021-12-31
2023-07-3112.63×2021-12-31
2023-08-3111.02×2021-12-31
2023-09-2911.81×2021-12-31
2023-10-3111.67×2021-12-31
2023-11-3011.49×2021-12-31
2023-12-2913.36×2021-12-31
2024-01-3112.58×2021-12-31
2024-02-2923.66×2022-12-31
2024-03-2825.38×2022-12-31
2024-04-3021.54×2022-12-31
2024-05-3118.96×2022-12-31
2024-06-2818.79×2022-12-31
2024-07-3119.19×2022-12-31
2024-08-3018.21×2022-12-31
2024-09-3020.01×2022-12-31
2024-10-3117.96×2022-12-31
2024-11-2919.04×2022-12-31
2024-12-3114.28×2022-12-31
2025-01-3117.97×2022-12-31
2025-02-289.68×2023-09-30
2025-03-319.97×2023-09-30
2025-04-309.82×2023-09-30
2025-05-309.43×2023-09-30
2025-06-3010.16×2023-09-30
2025-07-319.14×2023-09-30
2025-08-2910.77×2023-09-30
2025-09-3011.1×2023-09-30
2025-10-3111.51×2023-09-30
2025-11-2811.83×2023-09-30
2025-12-3111.68×2023-09-30
2026-01-3010.97×2023-09-30
2026-02-2758.11×2025-12-31
2026-03-3152.23×2025-12-31
2026-04-3060.58×2025-12-31
2026-05-2939.69×2026-03-31
2026-06-3045.13×2026-03-31
2026-07-3145.55×2026-03-31
2026-08-3124.72×2026-06-30
2026-09-2523.46×2026-06-30
Mean 18.38×Median 17.43×35% above median

ROIC

% · Annual / TTM

5.34%
Cvs Health ROIC. Reported fiscal history.
Fiscal period% · Annual / TTM
FY 2009 Q2—
FY 2009 Q3—
FY 2009 Q4—
FY 2010 Q1—
FY 2010 Q28.62%
FY 2010 Q38.11%
FY 2010 Q48.17%
FY 2011 Q18.11%
FY 2011 Q27.92%
FY 2011 Q38.08%
FY 2011 Q48.27%
FY 2012 Q18.64%
FY 2012 Q28.75%
FY 2012 Q39.07%
FY 2012 Q49.56%
FY 2013 Q110.1%
FY 2013 Q210.29%
FY 2013 Q310.78%
FY 2013 Q410.52%
FY 2014 Q1—
FY 2014 Q2—
FY 2014 Q3—
FY 2014 Q411.13%
FY 2015 Q1—
FY 2015 Q2—
FY 2015 Q3—
FY 2015 Q410.37%
FY 2016 Q1—
FY 2016 Q2—
FY 2016 Q3—
FY 2016 Q410.34%
FY 2017 Q1—
FY 2017 Q2—
FY 2017 Q3—
FY 2017 Q412.31%
FY 2018 Q113.01%
FY 2018 Q27.25%
FY 2018 Q37.59%
FY 2018 Q4—
FY 2019 Q1—
FY 2019 Q26.63%
FY 2019 Q36.98%
FY 2019 Q46.93%
FY 2020 Q17.31%
FY 2020 Q28.26%
FY 2020 Q38.32%
FY 2020 Q48.09%
FY 2021 Q18.2%
FY 2021 Q28.08%
FY 2021 Q38.12%
FY 2021 Q48.04%
FY 2022 Q18.07%
FY 2022 Q28.35%
FY 2022 Q34.29%
FY 2022 Q44.93%
FY 2023 Q14.66%
FY 2023 Q23.79%
FY 2023 Q39.08%
FY 2023 Q48.55%
FY 2024 Q17.68%
FY 2024 Q27.34%
FY 2024 Q35.52%
FY 2024 Q44.82%
FY 2025 Q15.4%
FY 2025 Q24.74%
FY 2025 Q30.55%
FY 2025 Q42.85%
FY 2026 Q13.81%
FY 2026 Q25.34%

Capital allocation

% of tracked cash uses

$3,342M
Cvs Health capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2009 Q280.65% · $625.3M5.07% · $39.3MUnavailable14.28% · $110.7MUnavailable100% · $775.3M
FY 2009 Q322.2% · $661.2M0.57% · $17M51.68% · $1,538.9M3.7% · $110.1M21.85% · $650.6M100% · $2,977.8M
FY 2009 Q441.86% · $795.5M3.04% · $57.7M49.37% · $938.1M5.69% · $108.2M0.04% · $0.7M100% · $1,900.2M
FY 2010 Q128.24% · $401M0.63% · $9M62.46% · $887M8.59% · $122M0.07% · $1M100% · $1,420M
FY 2010 Q215.69% · $465M0.54% · $16M20.69% · $613M4.02% · $119M59.06% · $1,750M100% · $2,963M
FY 2010 Q345.97% · $513M11.92% · $133M0% · $0M10.66% · $119M31.45% · $351M100% · $1,116M
FY 2010 Q481.83% · $626M2.48% · $19M0% · $0M15.56% · $119M0.13% · $1M100% · $765M
FY 2011 Q124.54% · $309M0.87% · $11M37.09% · $467M13.58% · $171M23.91% · $301M100% · $1,259M
FY 2011 Q216.5% · $401M55.74% · $1,355M20.73% · $504M6.99% · $170M0.04% · $1M100% · $2,431M
FY 2011 Q314.8% · $458M1.29% · $40M51.13% · $1,582M5.4% · $167M27.38% · $847M100% · $3,094M
FY 2011 Q430.27% · $704M1.5% · $35M19.26% · $448M7.14% · $166M41.83% · $973M100% · $2,326M
FY 2012 Q124.69% · $376M4.86% · $74M53.18% · $810M13.85% · $211M3.41% · $52M100% · $1,523M
FY 2012 Q221.66% · $442M9.8% · $200M58.21% · $1,188M10.24% · $209M0.1% · $2M100% · $2,041M
FY 2012 Q318.12% · $496M1.06% · $29M73.18% · $2,003M7.56% · $207M0.07% · $2M100% · $2,737M
FY 2012 Q423.99% · $716M2.51% · $75M11.03% · $329M6.77% · $202M55.7% · $1,662M100% · $2,984M
FY 2013 Q125.6% · $318M20.45% · $254M31.64% · $393M22.3% · $277M0% · $0M100% · $1,242M
FY 2013 Q241.79% · $486M3.96% · $46M30.52% · $355M23.73% · $276M0% · $0M100% · $1,163M
FY 2013 Q322.1% · $526M2.27% · $54M64.03% · $1,524M11.6% · $276M0% · $0M100% · $2,380M
FY 2013 Q424.34% · $654M2.27% · $61M63.42% · $1,704M9.97% · $268M0% · $0M100% · $2,687M
FY 2014 Q110.46% · $388M59.17% · $2,194M21.6% · $801M8.76% · $325MUnavailable100% · $3,708M
FY 2014 Q224.19% · $503M2.6% · $54M57.72% · $1,200M15.49% · $322MUnavailable100% · $2,079M
FY 2014 Q311.22% · $545M2.96% · $144M16.47% · $800M6.67% · $324M62.68% · $3,045M100% · $4,858M
FY 2014 Q430.73% · $700M2.06% · $47M52.68% · $1,200M13.92% · $317M0.61% · $14M100% · $2,278M
FY 2015 Q114.52% · $419M2.11% · $61M69.54% · $2,007M13.83% · $399MUnavailable100% · $2,886M
FY 2015 Q227.58% · $523M2.69% · $51M48.89% · $927M20.83% · $395MUnavailable100% · $1,896M
FY 2015 Q34.02% · $548M68.98% · $9,391M6.88% · $937M2.87% · $391M17.25% · $2,348M100% · $13,615M
FY 2015 Q420.05% · $877M45.08% · $1,972M25.83% · $1,130M8.94% · $391M0.09% · $4M100% · $4,374M
FY 2016 Q118.78% · $598M1.6% · $51M64.87% · $2,066M14.76% · $470MUnavailable100% · $3,185M
FY 2016 Q216.95% · $504M3.93% · $117M63.69% · $1,894M15.43% · $459MUnavailable100% · $2,974M
FY 2016 Q318.22% · $505M5.95% · $165M1.44% · $40M16.42% · $455M57.96% · $1,606M100% · $2,771M
FY 2016 Q424.7% · $617M8.25% · $206M18.45% · $461M18.25% · $456M30.34% · $758M100% · $2,498M
FY 2017 Q19.72% · $457M2.34% · $110M76.98% · $3,621M10.97% · $516MUnavailable100% · $4,704M
FY 2017 Q228.97% · $431M13.78% · $205M22.85% · $340M34.41% · $512MUnavailable100% · $1,488M
FY 2017 Q332.31% · $524M11.53% · $187M24.66% · $400M31.5% · $511MUnavailable100% · $1,622M
FY 2017 Q428.1% · $506M43.59% · $785M0% · $0M28.32% · $510MUnavailable100% · $1,801M
FY 2018 Q135.47% · $482M27.08% · $368MUnavailable37.38% · $508M0.07% · $1M100% · $1,359M
FY 2018 Q237.55% · $430M17.9% · $205MUnavailable44.54% · $510M0% · $0M100% · $1,145M
FY 2018 Q315.89% · $540M2.44% · $83MUnavailable15.01% · $510M66.66% · $2,265M100% · $3,398M
FY 2018 Q41.27% · $585M90.53% · $41,570MUnavailable1.11% · $510M7.09% · $3,256M100% · $45,921M
FY 2019 Q130.2% · $716M5.23% · $124MUnavailable27.37% · $649M37.2% · $882M100% · $2,371M
FY 2019 Q224.15% · $573M5.31% · $126MUnavailable27.69% · $657M42.86% · $1,017M100% · $2,373M
FY 2019 Q37.7% · $601M1.42% · $111MUnavailable8.27% · $646M82.61% · $6,451M100% · $7,809M
FY 2019 Q443.58% · $567M6.38% · $83MUnavailable50.04% · $651MUnavailable100% · $1,301M
FY 2020 Q124.61% · $742M20.33% · $613MUnavailable21.63% · $652M33.43% · $1,008M100% · $3,015M
FY 2020 Q235.16% · $448M12.17% · $155MUnavailable52.04% · $663M0.63% · $8M100% · $1,274M
FY 2020 Q34.97% · $534M0.56% · $60MUnavailable6.19% · $665M88.27% · $9,477M100% · $10,736M
FY 2020 Q410.91% · $713M0.58% · $38MUnavailable9.86% · $644M78.65% · $5,138M100% · $6,533M
FY 2021 Q117.95% · $829M1.82% · $84M0% · $0M14.21% · $656M66.02% · $3,049M100% · $4,618M
FY 2021 Q213.75% · $486M0.68% · $24M0% · $0M18.39% · $650M67.18% · $2,374M100% · $3,534M
FY 2021 Q316.46% · $608M0.73% · $27M0% · $0M17.84% · $659M64.97% · $2,400M100% · $3,694M
FY 2021 Q416.14% · $597M0.3% · $11M0% · $0M17.84% · $660M65.72% · $2,431M100% · $3,699M
FY 2022 Q127.7% · $1,051M0.18% · $7M52.71% · $2,000M19.03% · $722M0.37% · $14M100% · $3,794M
FY 2022 Q214.67% · $408M4.24% · $118M0% · $0M26.61% · $740M54.48% · $1,515M100% · $2,781M
FY 2022 Q314.58% · $580M0.15% · $6M0% · $0M18.25% · $726M67.02% · $2,666M100% · $3,978M
FY 2022 Q423.47% · $688M0.27% · $8M51.18% · $1,500M24.53% · $719M0.55% · $16M100% · $2,931M
FY 2023 Q18.76% · $984M63.13% · $7,094M17.96% · $2,018M6.93% · $779M3.22% · $362M100% · $11,237M
FY 2023 Q24.85% · $591M76.94% · $9,380MUnavailable6.52% · $795M11.69% · $1,425M100% · $12,191M
FY 2023 Q323.81% · $545M0.79% · $18MUnavailable34.03% · $779M41.37% · $947M100% · $2,289M
FY 2023 Q440.63% · $911M5.35% · $120MUnavailable34.75% · $779M19.27% · $432M100% · $2,242M
FY 2024 Q115.28% · $705M0.54% · $25M65.59% · $3,027M18.2% · $840M0.39% · $18M100% · $4,615M
FY 2024 Q240.82% · $638M3.07% · $48MUnavailable54.89% · $858M1.22% · $19M100% · $1,563M
FY 2024 Q321.02% · $670M0.38% · $12MUnavailable26.25% · $837M52.35% · $1,669M100% · $3,188M
FY 2024 Q416.4% · $768M0.21% · $10M0% · $0M17.89% · $838M65.49% · $3,067M100% · $4,683M
FY 2025 Q131.67% · $743M0.85% · $20M0% · $0M35.81% · $840M31.67% · $743M100% · $2,346M
FY 2025 Q237.68% · $607M7.39% · $119M0% · $0M53.76% · $866M1.18% · $19M100% · $1,611M
FY 2025 Q314.91% · $698M6.2% · $290M0% · $0M18.07% · $846M60.82% · $2,847M100% · $4,681M
FY 2025 Q447.34% · $784M0.42% · $7M0% · $0M51.03% · $845M1.21% · $20M100% · $1,656M
FY 2026 Q126.37% · $849M0.16% · $5MUnavailable26.31% · $847M47.16% · $1,518M100% · $3,219M
FY 2026 Q220.68% · $691M0.12% · $4MUnavailable26.27% · $878M52.93% · $1,769M100% · $3,342M

Tracked cash uses · SBC excluded

Sources and calculations

Company filings · USD · Last checked 2026-10-18. Missing inputs remain unavailable. Your chart selection and layout are saved in this browser for Cvs Health.

All charts share the selected dates. Quarterly/Yearly changes fiscal charts; valuation keeps completed daily closes on a published TTM basis. Later restatements can delay that basis. Historical mean, median and pricing labels use the selected range and do not estimate intrinsic fair value.

SBC deduction is an optional economic-cost scenario for FCF-based metrics. Missing SBC never becomes zero.

Revenue
Reported revenue from company filings.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Net margin
Reported net income / revenue × 100.
P/E
Completed closing price × diluted shares / TTM earnings attributable to common shareholders.
ROIC
NOPAT / average invested capital × 100. NOPAT = operating income × (1 − effective tax rate). Invested capital = equity including noncontrolling interests + debt − cash and equivalents. Average uses period end and one year earlier.
Capital allocation
Reported cash uses as a percentage of tracked uses. Missing categories remain unavailable; SBC is noncash and excluded.
Reported revenue and sources